Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Pesini

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Alzheimer'S Disease|February 11, 2014
Neprilysin is poorly expressed in the prefrontal cortex of aged dogs with cognitive dysfunction syndromeJesús Canudas, Daniel Insua, Leticia Sarasa, et al.
International Journal of Alzheimer'S Disease|September 8, 2012
Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of ADPedro Pesini, Virginia Pérez-Grijalba, Inmaculada Monleón, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in PlasmaVirginia Pérez-Grijalba, Noelia Fandos, Jesús Canudas, et al.
Neurology|March 18, 2020
Total Aβ<sub>42</sub>/Aβ<sub>40</sub> ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosisJames D Doecke, Virginia Pérez-Grijalba, Noelia Fandos, et al.
Experimental Gerontology|March 8, 2011
Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's diseaseÁngela González-Martínez, Belén Rosado, Pedro Pesini, et al.
Journal of Alzheimer'S Disease : JAD|June 4, 2016
Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's DiseaseJosé Antonio Allué, Leticia Sarasa, María Izco, et al.
Journal of Alzheimer'S Disease : JAD|May 3, 2013
Several direct and calculated biomarkers from the amyloid-β pool in blood are associated with an increased likelihood of suffering from mild cognitive impairmentVirginia Pérez-Grijalba, Pedro Pesini, Inmaculada Monleón, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 27, 2017
Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individualsNoelia Fandos, Virginia Pérez-Grijalba, Pedro Pesini, et al.
Journal of Alzheimer'S Disease : JAD|July 26, 2014
Aβ1-17 is a major amyloid-β fragment isoform in cerebrospinal fluid and blood with possible diagnostic value in Alzheimer's diseaseVirginia Pérez-Grijalba, Pedro Pesini, José Antonio Allué, et al.
Aging|September 28, 2019
Brain pyrimidine nucleotide synthesis and Alzheimer diseaseAlba Pesini, Eldris Iglesias, M Pilar Bayona-Bafaluy, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Alzheimer'S Disease|February 11, 2014
Neprilysin is poorly expressed in the prefrontal cortex of aged dogs with cognitive dysfunction syndromeJesús Canudas, Daniel Insua, Leticia Sarasa, et al.
International Journal of Alzheimer'S Disease|September 8, 2012
Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of ADPedro Pesini, Virginia Pérez-Grijalba, Inmaculada Monleón, et al.
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in PlasmaVirginia Pérez-Grijalba, Noelia Fandos, Jesús Canudas, et al.
Neurology|March 18, 2020
Total Aβ<sub>42</sub>/Aβ<sub>40</sub> ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosisJames D Doecke, Virginia Pérez-Grijalba, Noelia Fandos, et al.
Experimental Gerontology|March 8, 2011
Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's diseaseÁngela González-Martínez, Belén Rosado, Pedro Pesini, et al.
Journal of Alzheimer'S Disease : JAD|June 4, 2016
Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's DiseaseJosé Antonio Allué, Leticia Sarasa, María Izco, et al.
Journal of Alzheimer'S Disease : JAD|May 3, 2013
Several direct and calculated biomarkers from the amyloid-β pool in blood are associated with an increased likelihood of suffering from mild cognitive impairmentVirginia Pérez-Grijalba, Pedro Pesini, Inmaculada Monleón, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 27, 2017
Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individualsNoelia Fandos, Virginia Pérez-Grijalba, Pedro Pesini, et al.
Journal of Alzheimer'S Disease : JAD|July 26, 2014
Aβ1-17 is a major amyloid-β fragment isoform in cerebrospinal fluid and blood with possible diagnostic value in Alzheimer's diseaseVirginia Pérez-Grijalba, Pedro Pesini, José Antonio Allué, et al.
Aging|September 28, 2019
Brain pyrimidine nucleotide synthesis and Alzheimer diseaseAlba Pesini, Eldris Iglesias, M Pilar Bayona-Bafaluy, et al.
Pageof 4